Diabetes is ubiquitous, its prevalence is rising globally, and the social and economic burden caused is very huge. The highest healthcare and economic burden is on the developing countries which lodge more than 80% of the persons affected with the disease.\[[@ref1]\]

Optimal management of diabetes is of utmost importance to reduce the morbidity and mortality resulting from the disease and its associated vascular complications. The rising incidence of diabetes calls for urgent action to prevent the occurrence of new cases, that is, primary prevention is a major strategy to be adopted by every country. The number of adults with diabetes today is 382 million and is bound to increase to 592 million in 2035. The greatest number of people with diabetes is between 40 and 59 years of age. More than 80% of people with diabetes live in low- and middle-income countries.\[[@ref1]\]

Community-based randomized, controlled prevention trials, conducted in the past 2 decades have unequivocally shown that primary prevention of diabetes is possible in all ethnic groups by lifestyle modification (LSM) or by a few pharmacological agents.\[[@ref2]\] Extended trials such as the Chinese Da Qing study,\[[@ref3]\] the Diabetes Prevention Programme Outcomes Study (DPPOS) in USA,\[[@ref4]\] and the Finnish Diabetes Prevention Study\[[@ref5]\] have indicated that the benefits of LSM can last for periods, varying from 10 to 20 years.

Diabetes occurs from genetic and environmental interaction. Genetic factors do not change in a short period, hence the recent epidemic of the disease is mostly attributed to the rapid changes occurring in the environmental risk factors. Lifestyle transition related to diet, physical activity, and stress factors have been the chief determinants of the rising prevalence of diabetes seen in the developing countries.\[[@ref6][@ref7]\] These risk factors are mostly common for all noncommunicable diseases (NCDs).

Type 2 diabetes has a long asymptomatic stage, which when detected offers an opportunity to prevent the metabolic deterioration to diabetes. The nonmodifiable risk factors such as genetic factors, age, and ethnicity cannot be changed, however, behavior- and lifestyle-related factors such as obesity, physical inactivity, smoking, and excessive use of alcohol are the major modifiable factors. Prevalence of these is increasing phenomenally in developing countries. The prevalence of prediabetes consisting of impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) is rising globally. Its prevalence currently is around 316 million and is likely to rise to 471 million in another 20 years.\[[@ref1]\] Levels of prevention in type 2 diabetes are primordial, primary, secondary, and tertiary. The ideal approach to primary prevention would be the upstream strategy, wherein the total population is targeted for prevention. This is not practical in majority of the countries, especially in large nations like India with different levels of educational, geographic, and cultural barriers.

The downstream strategy in which the high-risk populations are targeted for prevention have been used successfully in all the major programs.\[[@ref2][@ref8]\] People with prediabetes and with a history of gestational diabetes mellitus have been chosen for these programs.\[[@ref8]\]

LSM using healthy diet, enhanced physical activity, and improved behavior have been used in the major prevention programs such as the China Da Qing study, the Finnish Diabetes Prevention Study, the DPP in the USA, the Indian Diabetes Prevention Programmes (IDPPs), and the Japanese Diabetes Prevention Study.\[[@ref2][@ref9]\] In all these programs, subjects with IGT/IFG have been studied for periods varying from 3 to 20 years. The American and the Finnish programs targeted individuals with obesity and one of the major goals of prevention was to reduce the body weight by LSM. The Asian studies had relatively leaner populations and weight loss had not been a major contributor to the improved outcome of LSM, that is, a lower incidence of diabetes compared to the control group who only had standard care.

Obesity, elevated levels of fasting or 2-h glucose, insulin resistance, and beta cell secretory defects were found to be highly predictive of the conversion to diabetes. LSM reduced obesity levels, improved insulin sensitivity and beta cell function resulting in reduced incidence of diabetes during the study period in western populations.\[[@ref2]\] In the Asian studies, the beneficial effects were independent of the reduction in body weight. Importantly, Indians who had high rate of insulin resistance with lower body mass index (BMI) in comparison with the western population were also benefitted by LSM.\[[@ref2][@ref9][@ref10]\]

A few pharmacological agents such as metformin, rosiglitazone, pioglitazone, and acarbose were also studied for their efficacy in preventing type 2 diabetes in high-risk subjects. Among these, metformin has been recommended as the safe pharmacological agent if LSM cannot be successfully implemented.\[[@ref11]\]

Preventing diabetes is of enormous value for any nation particularly in the developing world because of the high cost of treating diabetes and its complications.\[[@ref12]\] In India, it is estimated that a diabetic person spends a median of Rs. 10,000/annum for medical treatment. If diabetes can be prevented or delayed by LSM, this would result in a net gain in healthcare investments. The need of the hour is to develop pragmatic, cost effective strategies for primary prevention to extend the benefits to the population at large. Recent studies using information technology such as mobile phone-based SMS are now being tested for this purpose. In a recent 2-year program in India, we have demonstrated the effectiveness of SMS in educating and motivating men with IGT to follow LSM and this was found to be highly effective with a relative risk reduction of 36% compared to the participants who had only standard care.\[[@ref13]\]

For large-scale implementation of preventive strategies, the future plan should focus on health education of the public, improving the national capacity to detect and manage NCD\'s and development of innovative, cost effective, and scalable methodologies. The national programs such as the Finnish DEKHO\[[@ref14]\] and the study in Singapore\[[@ref15]\] initiated by the government should be taken as model endeavors to formulate strategies to promote and implement community health programs.
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